These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 15380148

  • 21. Obesity and the polycystic ovary syndrome.
    Magnotti M, Futterweit W.
    Med Clin North Am; 2007 Nov; 91(6):1151-68, ix-x. PubMed ID: 17964914
    [Abstract] [Full Text] [Related]

  • 22. Role of lifestyle modification in the management of polycystic ovary syndrome.
    Hoeger KM.
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):293-310. PubMed ID: 16772159
    [Abstract] [Full Text] [Related]

  • 23. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
    Soares EM, Azevedo GD, Gadelha RG, Lemos TM, Maranhão TM.
    Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
    [Abstract] [Full Text] [Related]

  • 24. Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women.
    Alexander CJ, Tangchitnob EP, Lepor NE.
    Rev Cardiovasc Med; 2009 Mar; 10(2):83-90. PubMed ID: 19593320
    [Abstract] [Full Text] [Related]

  • 25. [Long-term health consequences of polycystic ovaries syndrome: metabolic, cardiovascular and oncological aspects].
    Gutman G, Geva E, Lessing JB, Amster R.
    Harefuah; 2007 Nov; 146(11):889-93, 908. PubMed ID: 18087838
    [Abstract] [Full Text] [Related]

  • 26. Polycystic ovarian syndrome: the next cardiovascular dilemma in women?
    Srikanthan P, Korenman S, Davis S.
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):611-31, x. PubMed ID: 16959589
    [Abstract] [Full Text] [Related]

  • 27. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
    Bethea SW, Nestler JE.
    Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
    [Abstract] [Full Text] [Related]

  • 28. Insulin resistance in patients with polycystic ovary syndrome.
    Schröder AK, Tauchert S, Ortmann O, Diedrich K, Weiss JM.
    Ann Med; 2004 Dec; 36(6):426-39. PubMed ID: 15513294
    [Abstract] [Full Text] [Related]

  • 29. Cardiovascular risk in women with polycystic ovary syndrome.
    Cho LW, Atkin SL.
    Minerva Endocrinol; 2007 Dec; 32(4):263-73. PubMed ID: 18091663
    [Abstract] [Full Text] [Related]

  • 30. Stress in women: metabolic syndrome and polycystic ovary syndrome.
    Diamanti-Kandarakis E, Economou F.
    Ann N Y Acad Sci; 2006 Nov; 1083():54-62. PubMed ID: 17148733
    [Abstract] [Full Text] [Related]

  • 31. Association between the polycystic ovary syndrome and the metabolic syndrome in Puerto Rico.
    Rabelo Acevedo M, Vick MR.
    P R Health Sci J; 2005 Sep; 24(3):203-6. PubMed ID: 16329683
    [Abstract] [Full Text] [Related]

  • 32. Polycystic ovary syndrome and early-onset preeclampsia: reproductive manifestations of increased cardiovascular risk.
    Veltman-Verhulst SM, van Rijn BB, Westerveld HE, Franx A, Bruinse HW, Fauser BC, Goverde AJ.
    Menopause; 2010 Sep; 17(5):990-6. PubMed ID: 20551845
    [Abstract] [Full Text] [Related]

  • 33. Not all women diagnosed with PCOS share the same cardiovascular risk profiles.
    Jovanovic VP, Carmina E, Lobo RA.
    Fertil Steril; 2010 Aug; 94(3):826-32. PubMed ID: 19501355
    [Abstract] [Full Text] [Related]

  • 34. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
    Cussons AJ, Watts GF, Burke V, Shaw JE, Zimmet PZ, Stuckey BG.
    Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531
    [Abstract] [Full Text] [Related]

  • 35. Insulin resistance syndrome and polycystic ovary syndrome: implications for diagnosis and treatment.
    Tan S, Hahn S, Janssen OE.
    Panminerva Med; 2005 Dec; 47(4):211-7. PubMed ID: 16489320
    [Abstract] [Full Text] [Related]

  • 36. Insulin resistance and polycystic ovary syndrome.
    Galluzzo A, Amato MC, Giordano C.
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):511-8. PubMed ID: 18657405
    [Abstract] [Full Text] [Related]

  • 37. Polycystic ovary syndrome and cardiovascular disease.
    Loverro G.
    Minerva Endocrinol; 2004 Sep; 29(3):129-38. PubMed ID: 15282445
    [Abstract] [Full Text] [Related]

  • 38. Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome.
    Diamanti-Kandarakis E, Christakou C, Kandarakis H.
    Minerva Endocrinol; 2007 Mar; 32(1):35-47. PubMed ID: 17353865
    [Abstract] [Full Text] [Related]

  • 39. Exercise therapy in polycystic ovary syndrome.
    Hoeger KM.
    Semin Reprod Med; 2008 Jan; 26(1):93-100. PubMed ID: 18181087
    [Abstract] [Full Text] [Related]

  • 40. The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk.
    Amato MC, Verghi M, Galluzzo A, Giordano C.
    Hum Reprod; 2011 Jun; 26(6):1486-94. PubMed ID: 21447694
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.